143 related articles for article (PubMed ID: 32953931)
21. A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins.
Marino MP; Panigaj M; Ou W; Manirarora J; Wei CH; Reiser J
Gene Ther; 2015 Mar; 22(3):280-5. PubMed ID: 25608718
[TBL] [Abstract][Full Text] [Related]
22. Process intensification for lentiviral vector manufacturing using tangential flow depth filtration.
Tona RM; Shah R; Middaugh K; Steve J; Marques J; Roszell BR; Jung C
Mol Ther Methods Clin Dev; 2023 Jun; 29():93-107. PubMed ID: 36994313
[TBL] [Abstract][Full Text] [Related]
23. Insights into product and process related challenges of lentiviral vector bioprocessing.
Perry C; Mujahid N; Takeuchi Y; Rayat ACME
Biotechnol Bioeng; 2023 Aug; ():. PubMed ID: 37526313
[TBL] [Abstract][Full Text] [Related]
24. Lentiviral vector determinants of anion-exchange chromatography elution heterogeneity.
Pamenter G; Davies L; Lamont C; Rahim D; Knevelman C; Miskin J; Mitrophanous K; Dikicioglu D; Bracewell DG
Biotechnol Bioeng; 2024 Jun; ():. PubMed ID: 38874319
[TBL] [Abstract][Full Text] [Related]
25. Continuous manufacturing of lentiviral vectors using a stable producer cell line in a fixed-bed bioreactor.
Stibbs DJ; Silva Couto P; Takeuchi Y; Rafiq QA; Jackson NB; Rayat ACME
Mol Ther Methods Clin Dev; 2024 Mar; 32(1):101209. PubMed ID: 38435128
[TBL] [Abstract][Full Text] [Related]
26. A Scalable Lentiviral Vector Production and Purification Method Using Mustang Q Chromatography and Tangential Flow Filtration.
Tinch S; Szczur K; Swaney W; Reeves L; Witting SR
Methods Mol Biol; 2019; 1937():135-153. PubMed ID: 30706394
[TBL] [Abstract][Full Text] [Related]
27. Rapid high-performance liquid chromatographic analysis of adenovirus type 5 particles with a prototype anion-exchange analytical monolith column.
Whitfield RJ; Battom SE; Barut M; Gilham DE; Ball PD
J Chromatogr A; 2009 Mar; 1216(13):2725-9. PubMed ID: 19041094
[TBL] [Abstract][Full Text] [Related]
28. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
[TBL] [Abstract][Full Text] [Related]
29. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
Grieger JC; Soltys SM; Samulski RJ
Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
[TBL] [Abstract][Full Text] [Related]
30. A new scalable method for the purification of recombinant adenovirus vectors.
Green AP; Huang JJ; Scott MO; Kierstead TD; Beaupré I; Gao GP; Wilson JM
Hum Gene Ther; 2002 Nov; 13(16):1921-34. PubMed ID: 12427304
[TBL] [Abstract][Full Text] [Related]
31. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
32. Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes.
Frank AM; Buchholz CJ
Mol Ther Methods Clin Dev; 2019 Mar; 12():19-31. PubMed ID: 30417026
[TBL] [Abstract][Full Text] [Related]
33. Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing.
Tran MY; Kamen AA
Front Bioeng Biotechnol; 2022; 10():887716. PubMed ID: 35774066
[TBL] [Abstract][Full Text] [Related]
34. Validation of a high performance liquid chromatography method for quantitation of foot-and-mouth disease virus antigen in vaccines and vaccine manufacturing.
Spitteler MA; Romo A; Magi N; Seo MG; Yun SJ; Barroumeres F; Régulier EG; Bellinzoni R
Vaccine; 2019 Aug; 37(36):5288-5296. PubMed ID: 31353259
[TBL] [Abstract][Full Text] [Related]
35. Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use.
Lock D; Mockel-Tenbrinck N; Drechsel K; Barth C; Mauer D; Schaser T; Kolbe C; Al Rawashdeh W; Brauner J; Hardt O; Pflug N; Holtick U; Borchmann P; Assenmacher M; Kaiser A
Hum Gene Ther; 2017 Oct; 28(10):914-925. PubMed ID: 28847167
[TBL] [Abstract][Full Text] [Related]
36. Microfluidic Transduction Harnesses Mass Transport Principles to Enhance Gene Transfer Efficiency.
Tran R; Myers DR; Denning G; Shields JE; Lytle AM; Alrowais H; Qiu Y; Sakurai Y; Li WC; Brand O; Le Doux JM; Spencer HT; Doering CB; Lam WA
Mol Ther; 2017 Oct; 25(10):2372-2382. PubMed ID: 28780274
[TBL] [Abstract][Full Text] [Related]
37. Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing.
Radek C; Bernadin O; Drechsel K; Cordes N; Pfeifer R; Sträßer P; Mormin M; Gutierrez-Guerrero A; Cosset FL; Kaiser AD; Schaser T; Galy A; Verhoeyen E; Johnston ICD
Hum Gene Ther; 2019 Dec; 30(12):1477-1493. PubMed ID: 31578886
[TBL] [Abstract][Full Text] [Related]
38. Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography.
Eglon MN; Duffy AM; O'Brien T; Strappe PM
J Gene Med; 2009 Nov; 11(11):978-89. PubMed ID: 19670285
[TBL] [Abstract][Full Text] [Related]
39. Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells.
Leinonen HM; Lipponen EM; Valkama AJ; Hynynen H; Oruetxebarria I; Turkki V; Olsson V; Kurkipuro J; Samaranayake H; Määttä AM; Parker NR; Ylä-Herttuala S; Lesch HP
Mol Ther Methods Clin Dev; 2019 Dec; 15():63-71. PubMed ID: 31649956
[TBL] [Abstract][Full Text] [Related]
40. An HPLC-SEC-based rapid quantification method for vesicular stomatitis virus particles to facilitate process development.
Schimek A; Ng JKM; Basbas I; Martin F; Xin D; Saleh D; Hubbuch J
Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101252. PubMed ID: 38774583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
